Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Hemangioma 3Breast Neoplasms 3Smoldering Multiple Myeloma 1Postoperative Nausea and Vomiting 1Pain, Postoperative 1Pain 1Multiple Myeloma 1Hyperalgesia 1Hemangioma, Capillary 1Heart Failure 1Essential Hypertension 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Adrenergic beta-Antagonists × Clear all
NCT05972785 2024-08-21

Long-term Use of CCB and Breast Cancer Risk

Curtin University

Active not recruiting
68,500 enrolled
Breast

Essential Hypertension, Breast Neoplasms

NCT02907021 2020-10-09

SCHOLAR

Population Health Research Institute

Phase 1 Completed
20 enrolled
Breast

Breast Neoplasms, Heart Failure

NCT01544959 2018-10-24

PAINFree

Université de Sherbrooke

Phase NA Completed
84 enrolled
Breast

Breast Neoplasms, Hyperalgesia, Pain, Pain, Postoperative, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡